ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc (ORMP)

2,27
-0,03
(-1,30%)
Geschlossen 27 Januar 10:00PM
2,278
0,008
(0,35%)
Nach Börsenschluss: 1:59AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
2,27
Gebot
2,14
Fragen
2,39
Volumen
123.684
2,21 Tagesbereich 2,315
2,00 52-Wochen-Bereich 3,67
Marktkapitalisierung
Handelsende
2,30
Handelsbeginn
2,21
Letzte Trade
1
@
2.35
Letzter Handelszeitpunkt
Finanzvolumen
US$ 277.011
VWAP
2,2397
Durchschnittliches Volumen (3 Mio.)
161.214
Ausgegebene Aktien
40.312.069
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
16,63
Gewinn pro Aktie (EPS)
0,14
Erlöse
1,63M
Nettogewinn
5,53M

Über Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other p... Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Jerusalem, Jerusalem, Isr
Gegründet
-
Oramed Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ORMP. The last closing price for Oramed Pharmaceuticals was US$2,30. Over the last year, Oramed Pharmaceuticals shares have traded in a share price range of US$ 2,00 to US$ 3,67.

Oramed Pharmaceuticals currently has 40.312.069 shares in issue. The market capitalisation of Oramed Pharmaceuticals is US$92,72 million. Oramed Pharmaceuticals has a price to earnings ratio (PE ratio) of 16.63.

ORMP Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.05-2.155172413792.322.362.271140272.29411718CS
4-0.1-4.21940928272.372.52.271322542.37224163CS
12-0.1-4.21940928272.372.652.131612142.39410702CS
26-0.34-13.02681992342.612.722.11256392.3910664CS
52-0.09-3.813559322032.363.6721371542.55892211CS
156-6.01-72.58454106288.2813.731.675416784.99769601CS
260-2.99-56.84410646395.2631.541.675306327.93588681CS

ORMP - Frequently Asked Questions (FAQ)

What is the current Oramed Pharmaceuticals share price?
The current share price of Oramed Pharmaceuticals is US$ 2,27
How many Oramed Pharmaceuticals shares are in issue?
Oramed Pharmaceuticals has 40.312.069 shares in issue
What is the market cap of Oramed Pharmaceuticals?
The market capitalisation of Oramed Pharmaceuticals is USD 92,72M
What is the 1 year trading range for Oramed Pharmaceuticals share price?
Oramed Pharmaceuticals has traded in the range of US$ 2,00 to US$ 3,67 during the past year
What is the PE ratio of Oramed Pharmaceuticals?
The price to earnings ratio of Oramed Pharmaceuticals is 16,63
What is the cash to sales ratio of Oramed Pharmaceuticals?
The cash to sales ratio of Oramed Pharmaceuticals is 56,44
What is the reporting currency for Oramed Pharmaceuticals?
Oramed Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Oramed Pharmaceuticals?
The latest annual turnover of Oramed Pharmaceuticals is USD 1,63M
What is the latest annual profit for Oramed Pharmaceuticals?
The latest annual profit of Oramed Pharmaceuticals is USD 5,53M
What is the registered address of Oramed Pharmaceuticals?
The registered address for Oramed Pharmaceuticals is LLC, 1013 CENTER ROAD, SUITE 403-B, JERUSALEM, JERUSALEM, 19805
What is the Oramed Pharmaceuticals website address?
The website address for Oramed Pharmaceuticals is www.oramed.com
Which industry sector does Oramed Pharmaceuticals operate in?
Oramed Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock